Nova Patents
PL3313485T3

Hemostatic powder delivery devices

Abstract

This record has no abstract on file.

Term

9.7 yearsto projected expiry

Projected expiry 20 May 2036, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

31 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims14

Priority claims
DocumentOfficeKindDate
201562183916United States of AmericaP
201562183916United States of AmericaP
201615092712United States of AmericaA
201615092712United States of AmericaA
16732017European Patent Office (EPO)A
2016033444United States of AmericaW
2016033444United States of AmericaW
167320175–––
201562183916P–––
201615092712–––
EP20160732017–––
US201562183916P–––
US201615092712–––
WO2016US33444–––

Members31

Family members, oldest first
DocumentOfficeKind
CA2990593A1CanadaA1
US2016375202A1United States of AmericaA1
WO2016209442A1World Intellectual Property Organization (WIPO)A1
AU2016281539A1AustraliaA1
CN107801381AChinaA
MX2017016779AMexicoA
EP3313485A1European Patent Office (EPO)A1
JP2018518310AJapanA
BR112017027717A2BrazilA2
RU2018102283ARussian FederationA
RU2018102283A3Russian FederationA3
US10507293B2United States of AmericaB2
RU2714944C2Russian FederationC2
US2020061310A1United States of AmericaA1
RU2020105860ARussian FederationA
CN107801381BChinaB
EP3313485B1European Patent Office (EPO)B1
AU2016281539B2AustraliaB2
JP6746623B2JapanB2
PL3313485T3This recordPolandT3
EP3785753A1European Patent Office (EPO)A1
ES2819500T3SpainT3
MA53993AMoroccoA
US11154665B2United States of AmericaB2
US2022080132A1United States of AmericaA1
BR112017027717B1BrazilB1
EP3785753B1European Patent Office (EPO)B1
EP3785753C0European Patent Office (EPO)C0
US11717619B2United States of AmericaB2
PL3785753T3PolandT3
ES2952086T3SpainT3